The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Boyd Thomas A since year 2005.
The trader's CIK number is 1327433.
At the time of this reporting, Boyd Thomas A is the Sr. VP, Product Dev. of Progenics Pharmaceuticals Inc .
(stock ticker symbol PGNX).
See this page for all insider trading activities at Progenics Pharmaceuticals Inc .
Stock purchases, sales, and option exercises reported by insider Boyd Thomas A since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-10-01
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
4,384
6.53
28,627
2008-10-01
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
4,384
6.53
28,627
2008-07-01
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,921
13.64
39,842
2008-04-01
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
1,914
6.52
12,479
2008-01-02
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
692
15.33
10,608
2007-10-01
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,029
19.03
38,611
2007-10-01
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,029
19.03
38,611
2007-08-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2007-08-15
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
22.88
45,766
2007-07-16
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2007-07-16
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
21.51
43,019
2007-07-02
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
545
18.71
10,196
2007-06-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2007-06-15
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
22.03
44,055
2007-05-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2007-05-15
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
21.90
43,805
2007-04-16
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2007-04-16
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
26.94
53,874
2007-04-16
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2007-04-16
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
26.94
53,874
2007-04-02
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,018
20.13
40,622
2007-03-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2007-03-15
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
22.78
45,568
2007-02-15
PGNX
Progenics Pharmaceuticals Inc
Sale
4,000
29.97
119,896
2007-02-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
4,000
17.19
68,760
2007-01-03
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
428
21.88
9,364
2006-12-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
17.19
34,380
2006-12-15
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
26.05
52,100
2006-11-15
PGNX
Progenics Pharmaceuticals Inc
Sale
2,000
28.93
57,857
2006-11-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
2,000
15.41
30,815
2006-10-02
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
470
19.58
9,202
2006-07-03
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
1,986
20.45
40,615
2006-06-21
PGNX
Progenics Pharmaceuticals Inc
Sale
3,750
21.64
81,138
2006-04-03
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
376
21.77
8,185
2006-02-15
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
10,000
13.62
136,250
2006-02-15
PGNX
Progenics Pharmaceuticals Inc
Sale
10,000
28.00
280,000
2006-01-03
PGNX
Progenics Pharmaceuticals Inc
Option Exercise
367
20.86
7,655
2005-06-20
PGNX
Progenics Pharmaceuticals Inc
Sale
750
19.85
14,887
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Boyd Thomas A
(Sr. VP, Product Dev. of Progenics Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
